[
  {
    "title": "北陆药业(300016.SZ)：董事洪承杰完成减持1.45万股",
    "href": "http://stock.jrj.com.cn/2023/01/05154537261240.shtml",
    "datetime": "2023-01-05 15:45:32",
    "code": "300016"
  },
  {
    "title": "北陆药业(300016.SZ)：拟设立香港全资子公司",
    "href": "http://stock.jrj.com.cn/2022/12/27155037240521.shtml",
    "datetime": "2022-12-27 15:50:14",
    "code": "300016"
  },
  {
    "title": "北陆药业(300016.SZ)：121.84万股限制性股票待解锁 实际可上市流通数为60.97万股",
    "href": "http://stock.jrj.com.cn/2022/11/16183637144358.shtml",
    "datetime": "2022-11-16 18:36:34",
    "code": "300016"
  },
  {
    "title": "北陆药业2022年前三季度净利5523.46万同比下滑57.43% 研发投入大幅增加",
    "href": "http://stock.jrj.com.cn/2022/10/26205137087265.shtml",
    "datetime": "2022-10-26 20:51:15",
    "code": "300016"
  },
  {
    "title": "北陆药业(300016.SZ)第三季度净利润1523.11万元、同比增长14.82%",
    "href": "http://stock.jrj.com.cn/2022/10/26184737086634.shtml",
    "datetime": "2022-10-26 18:47:03",
    "code": "300016"
  },
  {
    "title": "北陆药业(300016.SZ)：瑞格列奈原料药获得上市申请批准通知书",
    "href": "http://stock.jrj.com.cn/2022/09/29162137031106.shtml",
    "datetime": "2022-09-29 16:21:18",
    "code": "300016"
  },
  {
    "title": "北陆药业(300016.SZ)：拟1000万元投设全资研发子公司北陆益康 完善研发体系",
    "href": "http://stock.jrj.com.cn/2022/09/01162236963154.shtml",
    "datetime": "2022-09-01 16:22:45",
    "code": "300016"
  },
  {
    "title": "北陆药业(300016.SZ)半年度净利润4000.34万元 同比下降65.66%",
    "href": "http://stock.jrj.com.cn/2022/08/26195636942337.shtml",
    "datetime": "2022-08-26 19:56:16",
    "code": "300016"
  },
  {
    "title": "北陆药业(300016.SZ)：碘帕醇注射液拟中标第七批全国药品集采",
    "href": "http://stock.jrj.com.cn/2022/07/12194836804513.shtml",
    "datetime": "2022-07-12 19:48:43",
    "code": "300016"
  },
  {
    "title": "海昌药业股东北京德福资产管理减持910万股 股东北京北陆药业增持910万股",
    "href": "http://stock.jrj.com.cn/2022/06/17195236739206.shtml",
    "datetime": "2022-06-17 19:52:54",
    "code": "300016"
  },
  {
    "title": "A股异动 | 北陆药业(300016.SZ)涨超8% 参股公司世和基因申报科创板上市获受理",
    "href": "http://stock.jrj.com.cn/2022/05/17104336654284.shtml",
    "datetime": "2022-05-17 10:43:51",
    "code": "300016"
  },
  {
    "title": "北陆药业(300016.SZ)：参股公司世和基因向上交所申报科创板上市获受理",
    "href": "http://stock.jrj.com.cn/2022/05/16173936651841.shtml",
    "datetime": "2022-05-16 17:39:10",
    "code": "300016"
  },
  {
    "title": "北陆药业2022年第一季度净利3926.33万同比减少22.18% 毛利减少",
    "href": "http://stock.jrj.com.cn/2022/05/04205036559800.shtml",
    "datetime": "2022-05-04 20:50:39",
    "code": "300016"
  },
  {
    "title": "北陆药业(300016.SZ)获得碘海醇注射液药品补充申请批准通知书",
    "href": "http://stock.jrj.com.cn/2022/04/06160036262722.shtml",
    "datetime": "2022-04-06 16:00:00",
    "code": "300016"
  },
  {
    "title": "北陆药业2021年净利润1.25亿元同比下滑28%：市场推广费1.97亿元",
    "href": "http://stock.jrj.com.cn/2022/03/30143136193064.shtml",
    "datetime": "2022-03-30 14:31:40",
    "code": "300016"
  },
  {
    "title": "北陆药业2021年净利1.25亿同比下滑28.46% 董事长WANG XU薪酬130.3万",
    "href": "http://stock.jrj.com.cn/2022/03/29225236161316.shtml",
    "datetime": "2022-03-29 22:52:38",
    "code": "300016"
  },
  {
    "title": "北陆药业(300016.SZ)：碘帕醇注射液通过一致性评价",
    "href": "http://stock.jrj.com.cn/2022/02/16154834368284.shtml",
    "datetime": "2022-02-16 15:48:25",
    "code": "300016"
  },
  {
    "title": "北陆药业(300016.SZ)：拟使用不超2.5亿元闲置募集资金、不超5亿元自有资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2022/01/21144234182343.shtml",
    "datetime": "2022-01-21 14:42:45",
    "code": "300016"
  },
  {
    "title": "北陆药业(300016.SZ)：拟出资5000万元参投华盖利晟 以投资首都大健康产业(北京)基金",
    "href": "http://stock.jrj.com.cn/2021/12/29160334081220.shtml",
    "datetime": "2021-12-29 16:03:34",
    "code": "300016"
  },
  {
    "title": "北陆药业：瑞格列奈片增加新规格并视同通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/12/17155134031676.shtml",
    "datetime": "2021-12-17 15:51:29",
    "code": "300016"
  },
  {
    "title": "北陆药业(300016.SZ)：海昌药业股票定向发行新增股份登记",
    "href": "http://stock.jrj.com.cn/2021/11/29220333940212.shtml",
    "datetime": "2021-11-29 22:03:54",
    "code": "300016"
  },
  {
    "title": "北陆药业股东王代雪减持314.56万股 套现约3221.09万 第三季度公司净利1326.48万",
    "href": "http://stock.jrj.com.cn/2021/11/24032033910580.shtml",
    "datetime": "2021-11-24 03:20:55",
    "code": "300016"
  },
  {
    "title": "北陆药业(300016.SZ)：实控人王代雪已减持314.56万股",
    "href": "http://stock.jrj.com.cn/2021/11/23160633909603.shtml",
    "datetime": "2021-11-23 16:06:47",
    "code": "300016"
  },
  {
    "title": "北陆药业股东宗利减持25万股 套现约235.5万 上半年公司净利1.16亿",
    "href": "http://stock.jrj.com.cn/2021/09/15184133440700.shtml",
    "datetime": "2021-09-15 18:41:18",
    "code": "300016"
  },
  {
    "title": "北陆药业(300016.SZ)：股东宗利累计减持25万股 减持计划完成",
    "href": "http://stock.jrj.com.cn/2021/09/15154933439748.shtml",
    "datetime": "2021-09-15 15:49:11",
    "code": "300016"
  },
  {
    "title": "A股公司CFO年龄梳理：北陆药业曾妮等10人年龄在30岁及以下",
    "href": "http://stock.jrj.com.cn/2021/09/14111833432952.shtml",
    "datetime": "2021-09-14 11:18:32",
    "code": "300016"
  },
  {
    "title": "北陆药业2021年半年度净利1.16亿元 同比净利增加27.21%",
    "href": "http://stock.jrj.com.cn/2021/08/20120733286177.shtml",
    "datetime": "2021-08-20 12:07:08",
    "code": "300016"
  },
  {
    "title": "对比剂业务产业链整合完成 北陆药业上半年净利润增长近四成",
    "href": "http://stock.jrj.com.cn/2021/08/20072333285010.shtml",
    "datetime": "2021-08-20 07:23:00",
    "code": "300016"
  },
  {
    "title": "北陆药业(300016.SZ)半年度净利润1.16亿元 同比增长27.21%",
    "href": "http://stock.jrj.com.cn/2021/08/19185033281807.shtml",
    "datetime": "2021-08-19 18:50:57",
    "code": "300016"
  },
  {
    "title": "北陆药业(300016.SZ)：实控人王代雪解押420.0001万股",
    "href": "http://stock.jrj.com.cn/2021/08/05155233206868.shtml",
    "datetime": "2021-08-05 15:52:07",
    "code": "300016"
  },
  {
    "title": "北陆药业(300016.SZ)：钆喷酸葡胺注射液通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/07/26160233152412.shtml",
    "datetime": "2021-07-26 16:02:03",
    "code": "300016"
  },
  {
    "title": "北陆药业(300016.SZ)：实控人王代雪解除质押350.0001万股",
    "href": "http://stock.jrj.com.cn/2021/07/08171933064792.shtml",
    "datetime": "2021-07-08 17:19:59",
    "code": "300016"
  },
  {
    "title": "北陆药业(300016.SZ)：董事长、总经理办理恢复中国国籍",
    "href": "http://stock.jrj.com.cn/2021/06/29155033015832.shtml",
    "datetime": "2021-06-29 15:50:44",
    "code": "300016"
  },
  {
    "title": "北陆药业拳头产品“碘克沙醇”在第五轮集采中出局 称将优化销售策略",
    "href": "http://stock.jrj.com.cn/2021/06/29121933015179.shtml",
    "datetime": "2021-06-29 12:19:11",
    "code": "300016"
  },
  {
    "title": "北陆药业：海昌药业预计下半年开始二期工程的试生产",
    "href": "http://stock.jrj.com.cn/2021/06/25085132994128.shtml",
    "datetime": "2021-06-25 08:51:39",
    "code": "300016"
  },
  {
    "title": "北陆药业：公司对比剂制剂产能可充分保障集采中标区域的稳定供应",
    "href": "http://stock.jrj.com.cn/2021/06/25084932994127.shtml",
    "datetime": "2021-06-25 08:49:46",
    "code": "300016"
  },
  {
    "title": "北陆药业：控股股东无出让控制权计划",
    "href": "http://stock.jrj.com.cn/2021/06/25082932993868.shtml",
    "datetime": "2021-06-25 08:29:53",
    "code": "300016"
  },
  {
    "title": "北陆药业：碘克沙醇注射液全国集采报量只占部分市场 执标后 公司仍可参与集采报量之外的市场",
    "href": "http://stock.jrj.com.cn/2021/06/25082832993862.shtml",
    "datetime": "2021-06-25 08:28:18",
    "code": "300016"
  },
  {
    "title": "北陆药业：公司共有两个对比剂产品参与本次国家集采 其中碘海醇注射液拟中标 碘克沙醇注射液未中标",
    "href": "http://stock.jrj.com.cn/2021/06/25082632993843.shtml",
    "datetime": "2021-06-25 08:26:12",
    "code": "300016"
  },
  {
    "title": "北陆药业(300016.SZ)：碘海醇注射液拟中标第五批全国药品集采",
    "href": "http://stock.jrj.com.cn/2021/06/23221032985463.shtml",
    "datetime": "2021-06-23 22:10:53",
    "code": "300016"
  },
  {
    "title": "北陆药业(300016.SZ)：实控人王代雪解除质押300万股",
    "href": "http://stock.jrj.com.cn/2021/06/21154632969514.shtml",
    "datetime": "2021-06-21 15:46:20",
    "code": "300016"
  },
  {
    "title": "北陆药业：公司对比剂产品适用于CT和MRI造影",
    "href": "http://stock.jrj.com.cn/2021/06/15115632933572.shtml",
    "datetime": "2021-06-15 11:56:23",
    "code": "300016"
  },
  {
    "title": "北陆药业：海昌药业生产经营活动正按年初制定的计划进行中",
    "href": "http://stock.jrj.com.cn/2021/06/15115632933563.shtml",
    "datetime": "2021-06-15 11:56:07",
    "code": "300016"
  },
  {
    "title": "北陆药业(300016.SZ)：“北陆转债”6月11日起开始转股",
    "href": "http://stock.jrj.com.cn/2021/06/08152532893331.shtml",
    "datetime": "2021-06-08 15:25:09",
    "code": "300016"
  },
  {
    "title": "北陆药业副总经理李海兵因酒驾，或被采取刑事强制措施",
    "href": "http://stock.jrj.com.cn/2021/06/01101732855830.shtml",
    "datetime": "2021-06-01 10:17:46",
    "code": "300016"
  },
  {
    "title": "北陆药业(300016.SZ)：副总经理李海兵因酒驾被采取刑事强制措施",
    "href": "http://stock.jrj.com.cn/2021/05/31194832851936.shtml",
    "datetime": "2021-05-31 19:48:00",
    "code": "300016"
  },
  {
    "title": "北陆药业(300016.SZ)：碘克沙醇注射液通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/05/31194532851869.shtml",
    "datetime": "2021-05-31 19:45:49",
    "code": "300016"
  },
  {
    "title": "北陆药业副总经理因酒驾被采取刑事强制措施",
    "href": "http://stock.jrj.com.cn/2021/05/31174132850983.shtml",
    "datetime": "2021-05-31 17:41:33",
    "code": "300016"
  },
  {
    "title": "北陆药业：副总经理因酒驾被采取刑事强制措施",
    "href": "http://stock.jrj.com.cn/2021/05/31170332850673.shtml",
    "datetime": "2021-05-31 17:03:52",
    "code": "300016"
  },
  {
    "title": "北陆药业：海昌药业新建850吨碘造影剂原料药项目碘克沙醇规划产能100吨 碘帕醇规划产能150吨",
    "href": "http://stock.jrj.com.cn/2021/05/31160632850097.shtml",
    "datetime": "2021-05-31 16:06:46",
    "code": "300016"
  },
  {
    "title": "渝三峡Ａ(000565.SZ)：出售北陆药业可转债 预计实现收益约440万元",
    "href": "http://stock.jrj.com.cn/2021/05/20163332787501.shtml",
    "datetime": "2021-05-20 16:33:10",
    "code": "300016"
  },
  {
    "title": "北陆药业(300016.SZ)：碘克沙醇注射液通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/05/17115032768478.shtml",
    "datetime": "2021-05-17 11:50:11",
    "code": "300016"
  },
  {
    "title": "北陆药业：公司参股的世和基因涉及肿瘤检测业务",
    "href": "http://stock.jrj.com.cn/2021/05/13171132749011.shtml",
    "datetime": "2021-05-13 17:11:59",
    "code": "300016"
  },
  {
    "title": "北陆药业：2020年度公司的九味镇心颗粒毛利率为66.95%",
    "href": "http://stock.jrj.com.cn/2021/05/13171032749010.shtml",
    "datetime": "2021-05-13 17:10:57",
    "code": "300016"
  },
  {
    "title": "北陆药业(300016.SZ)：持股22.38%的王代雪拟减持不超1.98%的股份",
    "href": "http://stock.jrj.com.cn/2021/04/30162932487534.shtml",
    "datetime": "2021-04-30 16:29:02",
    "code": "300016"
  },
  {
    "title": "北陆药业：公司已通过碘海醇注射液一致性评价",
    "href": "http://stock.jrj.com.cn/2021/04/21091032414322.shtml",
    "datetime": "2021-04-21 09:10:00",
    "code": "300016"
  },
  {
    "title": "北陆药业(300016.SZ)：碘海醇注射液通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/04/20161632410129.shtml",
    "datetime": "2021-04-20 16:16:54",
    "code": "300016"
  },
  {
    "title": "北陆药业：公司目前持有世和基因16.38%的股份",
    "href": "http://stock.jrj.com.cn/2021/04/19163932402480.shtml",
    "datetime": "2021-04-19 16:39:22",
    "code": "300016"
  },
  {
    "title": "北陆药业：公司降糖类产品实现销售收入7,095.35万元 同比减少19.02%",
    "href": "http://stock.jrj.com.cn/2021/03/24170932209304.shtml",
    "datetime": "2021-03-24 17:09:20",
    "code": "300016"
  },
  {
    "title": "北陆药业：公司参股公司世和基因已完成整体改制",
    "href": "http://stock.jrj.com.cn/2021/03/22155432194449.shtml",
    "datetime": "2021-03-22 15:54:09",
    "code": "300016"
  },
  {
    "title": "北陆药业：碘海醇销售下滑主要是因为2020年新建850吨碘造影剂原料药生产线仍处于建设期",
    "href": "http://stock.jrj.com.cn/2021/03/19160632164275.shtml",
    "datetime": "2021-03-19 16:06:01",
    "code": "300016"
  },
  {
    "title": "A股异动 | 北陆药业(300016.SZ)跌5.45% 2020年度净利降48.98%",
    "href": "http://stock.jrj.com.cn/2021/03/19110832162382.shtml",
    "datetime": "2021-03-19 11:08:33",
    "code": "300016"
  },
  {
    "title": "北陆药业2020年净利1.75亿下滑48.98% 董事长WANG XU薪酬141.99万",
    "href": "http://stock.jrj.com.cn/2021/03/18235532159870.shtml",
    "datetime": "2021-03-18 23:55:14",
    "code": "300016"
  },
  {
    "title": "北陆药业(300016.SZ)及海昌药业拟向银行申请不超14亿元综合授信",
    "href": "http://stock.jrj.com.cn/2021/03/18205532159309.shtml",
    "datetime": "2021-03-18 20:55:10",
    "code": "300016"
  },
  {
    "title": "北陆药业(300016.SZ)：2020年度净利降48.98%至1.75亿元 拟10派0.6元",
    "href": "http://stock.jrj.com.cn/2021/03/18200432158997.shtml",
    "datetime": "2021-03-18 20:04:16",
    "code": "300016"
  },
  {
    "title": "北陆药业(300016.SZ)再次通过高新技术企业认定",
    "href": "http://stock.jrj.com.cn/2021/02/09115931876522.shtml",
    "datetime": "2021-02-09 11:59:17",
    "code": "300016"
  },
  {
    "title": "北陆药业(300016.SZ)：“北陆转债”的转股价向下修正为8.86元/股",
    "href": "http://stock.jrj.com.cn/2021/02/05204831856333.shtml",
    "datetime": "2021-02-05 20:48:00",
    "code": "300016"
  },
  {
    "title": "北陆药业(300016.SZ)：控股股东累计减持“北陆转债”81.91万张",
    "href": "http://stock.jrj.com.cn/2021/01/21184231738390.shtml",
    "datetime": "2021-01-21 18:42:54",
    "code": "300016"
  },
  {
    "title": "北陆药业(300016.SZ)：拟使用不超2.5亿元闲置募集资金、不超5亿元自有资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2021/01/14221231694053.shtml",
    "datetime": "2021-01-14 22:12:42",
    "code": "300016"
  },
  {
    "title": "渝三峡Ａ(000565.SZ)：投入4091.37万元认购北陆药业可转债",
    "href": "http://stock.jrj.com.cn/2020/12/08163031440582.shtml",
    "datetime": "2020-12-08 16:30:20",
    "code": "300016"
  },
  {
    "title": "北陆药业(300016.SZ)可转债中签号码出炉：中签号共142845个",
    "href": "http://stock.jrj.com.cn/2020/12/08161231440379.shtml",
    "datetime": "2020-12-08 16:12:58",
    "code": "300016"
  },
  {
    "title": "北陆药业：公司可转债发行工作正在筹备中",
    "href": "http://stock.jrj.com.cn/2020/12/01154331384804.shtml",
    "datetime": "2020-12-01 15:43:08",
    "code": "300016"
  },
  {
    "title": "北陆药业：可转债项目获证监会批准注册 对比剂龙头企业产能新扩张",
    "href": "http://stock.jrj.com.cn/2020/11/06173931231442.shtml",
    "datetime": "2020-11-06 17:39:29",
    "code": "300016"
  },
  {
    "title": "北陆药业2020年前三季度净利1.61亿下滑3.98% 对联营公司确认投资收益减少",
    "href": "http://stock.jrj.com.cn/2020/10/30210431176997.shtml",
    "datetime": "2020-10-30 21:04:56",
    "code": "300016"
  },
  {
    "title": "北陆药业：海昌药业新厂一期项目正在试车阶段",
    "href": "http://stock.jrj.com.cn/2020/10/20171131093056.shtml",
    "datetime": "2020-10-20 17:11:19",
    "code": "300016"
  },
  {
    "title": "北陆药业2020年上半年净利9156.38万下滑18.26% 物流运输受到管控",
    "href": "http://stock.jrj.com.cn/2020/08/12103330480439.shtml",
    "datetime": "2020-08-12 10:33:55",
    "code": "300016"
  },
  {
    "title": "【龙虎榜】北陆药业7月30日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/30180030386241.shtml",
    "datetime": "2020-07-30 18:00:00",
    "code": "300016"
  },
  {
    "title": "北陆药业：公司3药品获得再注册批件",
    "href": "http://stock.jrj.com.cn/2020/06/23172030000146.shtml",
    "datetime": "2020-06-23 17:20:33",
    "code": "300016"
  },
  {
    "title": "北陆药业第一季净利润2678.46万同比减少33.97% 疫情影响所致",
    "href": "http://stock.jrj.com.cn/2020/05/02143229462805.shtml",
    "datetime": "2020-05-02 14:32:10",
    "code": "300016"
  },
  {
    "title": "北陆药业：格列美脲片等药品取得再注册批件",
    "href": "http://stock.jrj.com.cn/2020/04/17165029314059.shtml",
    "datetime": "2020-04-17 16:50:00",
    "code": "300016"
  },
  {
    "title": "北陆药业：拟公开发行不超5亿元可转债",
    "href": "http://stock.jrj.com.cn/2020/03/31201529160289.shtml",
    "datetime": "2020-03-31 20:15:00",
    "code": "300016"
  },
  {
    "title": "北陆药业：拟发行可转债募资不超5亿元",
    "href": "http://stock.jrj.com.cn/2020/03/31195129160138.shtml",
    "datetime": "2020-03-31 19:51:57",
    "code": "300016"
  },
  {
    "title": "北陆药业拟为控股子公司不超过人民币1.5亿元综合授信额度提供连带责任保证",
    "href": "http://stock.jrj.com.cn/2020/03/20190529071281.shtml",
    "datetime": "2020-03-20 19:05:39",
    "code": "300016"
  },
  {
    "title": "会议费等5项费用超扣非净利润 北陆药业一年花5398万元开会",
    "href": "http://stock.jrj.com.cn/2020/03/18083229049421.shtml",
    "datetime": "2020-03-18 08:32:37",
    "code": "300016"
  },
  {
    "title": "北陆药业：2019年年度报告主要财务指标及分配预案",
    "href": "http://stock.jrj.com.cn/2020/03/11213029003446.shtml",
    "datetime": "2020-03-11 21:30:00",
    "code": "300016"
  },
  {
    "title": "北陆药业：2020年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/03/11210029003327.shtml",
    "datetime": "2020-03-11 21:00:00",
    "code": "300016"
  },
  {
    "title": "北陆药业去年营收首次突破8亿 净利同比增长131.75%",
    "href": "http://stock.jrj.com.cn/2020/03/11205429003311.shtml",
    "datetime": "2020-03-11 20:54:21",
    "code": "300016"
  },
  {
    "title": "北陆药业：2019年实现净利润3.42亿元 同比增长131.75%",
    "href": "http://stock.jrj.com.cn/2020/03/11205129003307.shtml",
    "datetime": "2020-03-11 20:51:00",
    "code": "300016"
  },
  {
    "title": "北陆药业持续发力：2019年实现净利润3.42亿元 同比增长131.75%",
    "href": "http://stock.jrj.com.cn/2020/03/11203429003209.shtml",
    "datetime": "2020-03-11 20:34:00",
    "code": "300016"
  },
  {
    "title": "北陆药业：2019年净利3.42亿元 同比增长132%",
    "href": "http://stock.jrj.com.cn/2020/03/11200029003105.shtml",
    "datetime": "2020-03-11 20:00:12",
    "code": "300016"
  },
  {
    "title": "北陆药业：2019年净利同比增131.75%",
    "href": "http://stock.jrj.com.cn/2020/03/11193529003013.shtml",
    "datetime": "2020-03-11 19:35:00",
    "code": "300016"
  },
  {
    "title": "北陆药业：2019年实现净利润3.42亿元 同比增长131.75%",
    "href": "http://stock.jrj.com.cn/2020/02/26205128899585.shtml",
    "datetime": "2020-02-26 20:51:00",
    "code": "300016"
  },
  {
    "title": "北陆药业2019年净利润增长131.75%",
    "href": "http://stock.jrj.com.cn/2020/02/26181228898348.shtml",
    "datetime": "2020-02-26 18:12:26",
    "code": "300016"
  },
  {
    "title": "公司各项业务发展势头良好 北陆药业2019年净利同比增长131.75%",
    "href": "http://stock.jrj.com.cn/2020/02/26180928898335.shtml",
    "datetime": "2020-02-26 18:09:00",
    "code": "300016"
  },
  {
    "title": "北陆药业2019年盈利3.42亿元增长132% 销售收入均持续增长",
    "href": "http://stock.jrj.com.cn/2020/02/26164628897884.shtml",
    "datetime": "2020-02-26 16:46:10",
    "code": "300016"
  },
  {
    "title": "北陆药业：2019年净利3.42亿元 同比增长132%",
    "href": "http://stock.jrj.com.cn/2020/02/26163828897848.shtml",
    "datetime": "2020-02-26 16:38:32",
    "code": "300016"
  },
  {
    "title": "北陆药业：钆贝葡胺注射液获得药品注册批件",
    "href": "http://stock.jrj.com.cn/2020/02/11182328810432.shtml",
    "datetime": "2020-02-11 18:23:29",
    "code": "300016"
  },
  {
    "title": "北陆药业：新取得一项注射液药品注册批件 对比剂系列产品增至六个品种",
    "href": "http://stock.jrj.com.cn/2020/02/11164128809901.shtml",
    "datetime": "2020-02-11 16:41:07",
    "code": "300016"
  },
  {
    "title": "北陆药业：钆贝葡胺注射液获药品注册批件",
    "href": "http://stock.jrj.com.cn/2020/02/11155428809704.shtml",
    "datetime": "2020-02-11 15:54:00",
    "code": "300016"
  },
  {
    "title": "北陆药业：获得钆贝葡胺注射液注册批件",
    "href": "http://stock.jrj.com.cn/2020/02/11154728809680.shtml",
    "datetime": "2020-02-11 15:47:33",
    "code": "300016"
  },
  {
    "title": "北陆药业将捐赠百万元物资驰援武汉",
    "href": "http://stock.jrj.com.cn/2020/01/27132228737600.shtml",
    "datetime": "2020-01-27 13:22:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]北陆药业将捐赠百万元物资驰援武汉",
    "href": "http://stock.jrj.com.cn/2020/01/24000031534655.shtml",
    "datetime": "2020-01-24 00:00:00",
    "code": "300016"
  },
  {
    "title": "北陆药业2019年预计净利3.18亿元—3.62亿元 同比增长115%—145%",
    "href": "http://stock.jrj.com.cn/2020/01/20183228707095.shtml",
    "datetime": "2020-01-20 18:32:49",
    "code": "300016"
  },
  {
    "title": "[北陆药业]“新梦想,心启航”:北陆药业2019年年度盛典圆满落幕",
    "href": "http://stock.jrj.com.cn/2020/01/20000031534649.shtml",
    "datetime": "2020-01-20 00:00:00",
    "code": "300016"
  },
  {
    "title": "北陆药业参加了格列美脲片拟中标第二批全国药品集中采购",
    "href": "http://stock.jrj.com.cn/2020/01/19212028702416.shtml",
    "datetime": "2020-01-19 21:20:29",
    "code": "300016"
  },
  {
    "title": "北陆药业：格列美脲片拟中标全国药品集中采购",
    "href": "http://stock.jrj.com.cn/2020/01/19182628701774.shtml",
    "datetime": "2020-01-19 18:26:05",
    "code": "300016"
  },
  {
    "title": "北陆药业聘任匡夏思为副总经理",
    "href": "http://stock.jrj.com.cn/2020/01/09172528650672.shtml",
    "datetime": "2020-01-09 17:25:48",
    "code": "300016"
  },
  {
    "title": "[北陆药业]北陆药业荣获密云优化营商环境服务大会“高精尖示范企业奖”等四项大奖!",
    "href": "http://stock.jrj.com.cn/2020/01/09000031534650.shtml",
    "datetime": "2020-01-09 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]北陆药业荣获中关村民营科技企业家协会“2019年度优秀企业奖”",
    "href": "http://stock.jrj.com.cn/2020/01/08000031534644.shtml",
    "datetime": "2020-01-08 00:00:00",
    "code": "300016"
  },
  {
    "title": "北陆药业聘任李海兵为副总经理",
    "href": "http://stock.jrj.com.cn/2019/12/23220128574719.shtml",
    "datetime": "2019-12-23 22:01:27",
    "code": "300016"
  },
  {
    "title": "海昌药业股东北陆药业增持51.1万股",
    "href": "http://stock.jrj.com.cn/2019/12/17000628542570.shtml",
    "datetime": "2019-12-17 00:06:13",
    "code": "300016"
  },
  {
    "title": "[北陆药业]你这么努力,为什么还这么焦虑",
    "href": "http://stock.jrj.com.cn/2019/12/13000031534643.shtml",
    "datetime": "2019-12-13 00:00:00",
    "code": "300016"
  },
  {
    "title": "北陆药业：收购海昌药业 加强对比剂原料药布局",
    "href": "http://stock.jrj.com.cn/2019/12/09194028510091.shtml",
    "datetime": "2019-12-09 19:40:16",
    "code": "300016"
  },
  {
    "title": "[北陆药业]重磅!北陆药业收购海昌药业,加强对比剂原料药布局",
    "href": "http://stock.jrj.com.cn/2019/12/09000031534667.shtml",
    "datetime": "2019-12-09 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]北陆药业荣获“2019金紫荆·最佳公司治理上市公司奖”",
    "href": "http://stock.jrj.com.cn/2019/12/06000031534645.shtml",
    "datetime": "2019-12-06 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]【喜讯】九味镇心颗粒获评“北京市新技术新产品”",
    "href": "http://stock.jrj.com.cn/2019/10/29000031534657.shtml",
    "datetime": "2019-10-29 00:00:00",
    "code": "300016"
  },
  {
    "title": "北陆药业三季报业绩持续“飘红” 营收净利增速均超30%",
    "href": "http://stock.jrj.com.cn/2019/10/21182728278353.shtml",
    "datetime": "2019-10-21 18:27:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]北陆药业三季报业绩持续“飘红”,营收净利增速均超30%",
    "href": "http://stock.jrj.com.cn/2019/10/21000031534656.shtml",
    "datetime": "2019-10-21 00:00:00",
    "code": "300016"
  },
  {
    "title": "北陆药业：2019年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/10/11223028235538.shtml",
    "datetime": "2019-10-11 22:30:00",
    "code": "300016"
  },
  {
    "title": "北陆药业2019年前三季度净利约1.52亿元—1.77亿元 销售收入持续增长",
    "href": "http://stock.jrj.com.cn/2019/10/11175928234103.shtml",
    "datetime": "2019-10-11 17:59:25",
    "code": "300016"
  },
  {
    "title": "[北陆药业]2019世界精神卫生日—“北陆健康科普活动”",
    "href": "http://stock.jrj.com.cn/2019/10/11000031534641.shtml",
    "datetime": "2019-10-11 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]北陆药业新版官网正式全面上线!",
    "href": "http://stock.jrj.com.cn/2019/10/08000031534634.shtml",
    "datetime": "2019-10-08 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]北陆药业推出股权激励计划:力争明年营收冲击10亿!",
    "href": "http://stock.jrj.com.cn/2019/09/20000031534651.shtml",
    "datetime": "2019-09-20 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]北陆药业上榜“中国创业板上市公司价值五十强”",
    "href": "http://stock.jrj.com.cn/2019/08/11000031534658.shtml",
    "datetime": "2019-08-11 00:00:00",
    "code": "300016"
  },
  {
    "title": "北陆药业股东重庆三峡误操作导致短线交易及减持计划终止",
    "href": "http://stock.jrj.com.cn/2019/08/03104327925168.shtml",
    "datetime": "2019-08-03 10:43:55",
    "code": "300016"
  },
  {
    "title": "“乌龙指”错将买入当卖出 渝三峡A提前终止减持北陆药业",
    "href": "http://stock.jrj.com.cn/2019/08/02200727924827.shtml",
    "datetime": "2019-08-02 20:07:46",
    "code": "300016"
  },
  {
    "title": "北陆药业2019年上半年盈利1.12亿 销售稳定增长",
    "href": "http://stock.jrj.com.cn/2019/07/26085327889837.shtml",
    "datetime": "2019-07-26 08:53:40",
    "code": "300016"
  },
  {
    "title": "北陆药业：2019年半年度报告主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/07/25211027888183.shtml",
    "datetime": "2019-07-25 21:10:00",
    "code": "300016"
  },
  {
    "title": "北陆药业“中考”成绩单：2019半年度净利增速超30%",
    "href": "http://stock.jrj.com.cn/2019/07/25201827888005.shtml",
    "datetime": "2019-07-25 20:18:00",
    "code": "300016"
  },
  {
    "title": "北陆药业：上半年净利1.12亿元 同比增长32%",
    "href": "http://stock.jrj.com.cn/2019/07/25201527887987.shtml",
    "datetime": "2019-07-25 20:15:04",
    "code": "300016"
  },
  {
    "title": "北陆药业上半年净利润同比增长32.27%",
    "href": "http://stock.jrj.com.cn/2019/07/25194527887906.shtml",
    "datetime": "2019-07-25 19:45:44",
    "code": "300016"
  },
  {
    "title": "北陆药业：上半年净利1.12亿元 同比增32%",
    "href": "http://stock.jrj.com.cn/2019/07/25192727887847.shtml",
    "datetime": "2019-07-25 19:27:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]北陆药业“中考”成绩单:2019半年度净利增速超30% !",
    "href": "http://stock.jrj.com.cn/2019/07/23000031534653.shtml",
    "datetime": "2019-07-23 00:00:00",
    "code": "300016"
  },
  {
    "title": "北陆药业2019年上半年净利1.02亿—1.19亿 同比增长20%—40%",
    "href": "http://stock.jrj.com.cn/2019/07/13103727836351.shtml",
    "datetime": "2019-07-13 10:37:33",
    "code": "300016"
  },
  {
    "title": "[北陆药业]北陆药业2019年半年度业绩预告:净利润同比增长20%-40%",
    "href": "http://stock.jrj.com.cn/2019/07/12000031534637.shtml",
    "datetime": "2019-07-12 00:00:00",
    "code": "300016"
  },
  {
    "title": "北陆药业布局AI医疗 战略投资“脑医生”3000万元",
    "href": "http://stock.jrj.com.cn/2019/07/05183327802871.shtml",
    "datetime": "2019-07-05 18:33:59",
    "code": "300016"
  },
  {
    "title": "北陆药业：拟斥资3000万元增资铱硙医疗",
    "href": "http://stock.jrj.com.cn/2019/07/05171327802280.shtml",
    "datetime": "2019-07-05 17:13:58",
    "code": "300016"
  },
  {
    "title": "北陆药业：拟3000万元增资铱硙医疗",
    "href": "http://stock.jrj.com.cn/2019/07/05162627802092.shtml",
    "datetime": "2019-07-05 16:26:00",
    "code": "300016"
  },
  {
    "title": "北陆药业：公司格列美脲片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2019/07/03175027792255.shtml",
    "datetime": "2019-07-03 17:50:58",
    "code": "300016"
  },
  {
    "title": "北陆药业：格列美脲片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2019/07/03174427792165.shtml",
    "datetime": "2019-07-03 17:44:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]北陆药业布局AI医疗 战略投资“脑医生”3000万元",
    "href": "http://stock.jrj.com.cn/2019/07/03000031534654.shtml",
    "datetime": "2019-07-03 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]【重磅】公司格列美脲片通过仿制药一致性评价!",
    "href": "http://stock.jrj.com.cn/2019/07/02000031534642.shtml",
    "datetime": "2019-07-02 00:00:00",
    "code": "300016"
  },
  {
    "title": "渝三峡A：出售北陆药业股票65万股",
    "href": "http://stock.jrj.com.cn/2019/06/20215427732874.shtml",
    "datetime": "2019-06-20 21:54:36",
    "code": "300016"
  },
  {
    "title": "渝三峡A：出售北陆药业部分股票",
    "href": "http://stock.jrj.com.cn/2019/06/20194727732430.shtml",
    "datetime": "2019-06-20 19:47:00",
    "code": "300016"
  },
  {
    "title": "渝三峡A出售北陆药业部分股票",
    "href": "http://stock.jrj.com.cn/2019/06/20193027732370.shtml",
    "datetime": "2019-06-20 19:30:34",
    "code": "300016"
  },
  {
    "title": "[北陆药业]九味镇心颗粒获评“2019年双创周中关村新技术新产品”",
    "href": "http://stock.jrj.com.cn/2019/06/14000031534635.shtml",
    "datetime": "2019-06-14 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]九味镇心颗粒——“给你一份改善心情的礼物”",
    "href": "http://stock.jrj.com.cn/2019/05/17000031534636.shtml",
    "datetime": "2019-05-17 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]北陆药业荣膺第十届“天马奖·最佳董事会奖”",
    "href": "http://stock.jrj.com.cn/2019/04/24000031534633.shtml",
    "datetime": "2019-04-24 00:00:00",
    "code": "300016"
  },
  {
    "title": "北陆药业一季度营收和净利增幅双双超过40%",
    "href": "http://stock.jrj.com.cn/2019/04/15175427398056.shtml",
    "datetime": "2019-04-15 17:54:22",
    "code": "300016"
  },
  {
    "title": "北陆药业2019年一季度业绩“开门红” 营收净利增速均超40%",
    "href": "http://stock.jrj.com.cn/2019/04/15173327397665.shtml",
    "datetime": "2019-04-15 17:33:00",
    "code": "300016"
  },
  {
    "title": "北陆药业：一季度净利同比增41%",
    "href": "http://stock.jrj.com.cn/2019/04/15171527397570.shtml",
    "datetime": "2019-04-15 17:15:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]北陆药业一季度业绩“开门红”!营收净利增速均超40%!",
    "href": "http://stock.jrj.com.cn/2019/04/12000031534632.shtml",
    "datetime": "2019-04-12 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]北陆药业2019年一季度业绩“飘红”,净利润增幅达XX%",
    "href": "http://stock.jrj.com.cn/2019/04/12000031534631.shtml",
    "datetime": "2019-04-12 00:00:00",
    "code": "300016"
  },
  {
    "title": "北陆药业：大股东渝三峡拟减持不超1.98%股份",
    "href": "http://stock.jrj.com.cn/2019/04/11213727369001.shtml",
    "datetime": "2019-04-11 21:37:45",
    "code": "300016"
  },
  {
    "title": "北陆药业：股东拟减持公司不超1.98%股权",
    "href": "http://stock.jrj.com.cn/2019/04/11185327368341.shtml",
    "datetime": "2019-04-11 18:53:00",
    "code": "300016"
  },
  {
    "title": "北陆药业：持股9.2%的股东拟减持不超1.98%",
    "href": "http://stock.jrj.com.cn/2019/04/11183327368191.shtml",
    "datetime": "2019-04-11 18:33:26",
    "code": "300016"
  },
  {
    "title": "渝三峡A：拟择机出售不超970万股北陆药业股票",
    "href": "http://stock.jrj.com.cn/2019/03/20184727198240.shtml",
    "datetime": "2019-03-20 18:47:44",
    "code": "300016"
  },
  {
    "title": "[北陆药业]北陆网络学院:骨放射专场",
    "href": "http://stock.jrj.com.cn/2019/03/08000031534647.shtml",
    "datetime": "2019-03-08 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]北陆药业博士后科研工作站正式授牌成立!",
    "href": "http://stock.jrj.com.cn/2019/03/01000031534622.shtml",
    "datetime": "2019-03-01 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]北陆药业博士后科研工作站正式授牌成立!",
    "href": "http://stock.jrj.com.cn/2019/03/01000031534811.shtml",
    "datetime": "2019-03-01 00:00:00",
    "code": "300016"
  },
  {
    "title": "北陆药业：2019年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/02/28113027101472.shtml",
    "datetime": "2019-02-28 11:30:00",
    "code": "300016"
  },
  {
    "title": "去年营收破6亿净利润同比增逾两成 北陆药业涨停",
    "href": "http://stock.jrj.com.cn/2019/02/28094627101059.shtml",
    "datetime": "2019-02-28 09:46:43",
    "code": "300016"
  },
  {
    "title": "北陆药业去年营收首破6亿 净利润同比增逾两成",
    "href": "http://stock.jrj.com.cn/2019/02/28034827099567.shtml",
    "datetime": "2019-02-28 03:48:20",
    "code": "300016"
  },
  {
    "title": "北陆药业：2018年净利润同比增长24% 拟10派1",
    "href": "http://stock.jrj.com.cn/2019/02/27191727098388.shtml",
    "datetime": "2019-02-27 19:17:00",
    "code": "300016"
  },
  {
    "title": "北陆药业：公司获得《药品GMP证书》",
    "href": "http://stock.jrj.com.cn/2019/02/19171827062967.shtml",
    "datetime": "2019-02-19 17:18:29",
    "code": "300016"
  },
  {
    "title": "[北陆药业]【重磅】公司获得钆喷酸葡胺原料药GMP证书",
    "href": "http://stock.jrj.com.cn/2019/02/19000031534646.shtml",
    "datetime": "2019-02-19 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]【重磅】公司喜获钆喷酸葡胺原料药GMP证书",
    "href": "http://stock.jrj.com.cn/2019/02/19000031534648.shtml",
    "datetime": "2019-02-19 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]【重磅】公司获得钆喷酸葡胺原料药GMP证书",
    "href": "http://stock.jrj.com.cn/2019/02/18000031534639.shtml",
    "datetime": "2019-02-18 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]最新带量采购:原研药不降价,就出局",
    "href": "http://stock.jrj.com.cn/2019/02/01000027655615.shtml",
    "datetime": "2019-02-01 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]国务院发文,医院药占比考核取消!耗占比...",
    "href": "http://stock.jrj.com.cn/2019/02/01000027012334.shtml",
    "datetime": "2019-02-01 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]中成药价格上涨 是“超前”还是“滞后”",
    "href": "http://stock.jrj.com.cn/2019/02/01000027285428.shtml",
    "datetime": "2019-02-01 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]药品管理法修改:取消GMP/GSP认证,重罚违法药企",
    "href": "http://stock.jrj.com.cn/2019/02/01000027526562.shtml",
    "datetime": "2019-02-01 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]医药流通行业:回想2018年与展望2019年",
    "href": "http://stock.jrj.com.cn/2019/02/01000027913102.shtml",
    "datetime": "2019-02-01 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]国家医保局开会了 传递重要信号",
    "href": "http://stock.jrj.com.cn/2019/01/09000027010914.shtml",
    "datetime": "2019-01-09 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]医药流通行业:回想2018年与展望2019年",
    "href": "http://stock.jrj.com.cn/2019/01/09000026879159.shtml",
    "datetime": "2019-01-09 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]国家药监局:推动一致性评价 加快仿制药上市",
    "href": "http://stock.jrj.com.cn/2019/01/09000027104450.shtml",
    "datetime": "2019-01-09 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]近期药政重点:落实“两票制”,打击过票洗钱!",
    "href": "http://stock.jrj.com.cn/2019/01/09000027526560.shtml",
    "datetime": "2019-01-09 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]集中采购试点工作进入实施阶段 消除药品购销灰色空间",
    "href": "http://stock.jrj.com.cn/2019/01/09000027776479.shtml",
    "datetime": "2019-01-09 00:00:00",
    "code": "300016"
  },
  {
    "title": "北陆药业：2018年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/01/02163026842029.shtml",
    "datetime": "2019-01-02 16:30:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]国家基药政策,或有大调整",
    "href": "http://stock.jrj.com.cn/2018/12/20000027104449.shtml",
    "datetime": "2018-12-20 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]官方发文:未过一致性评价,注销批文!",
    "href": "http://stock.jrj.com.cn/2018/12/20000027655614.shtml",
    "datetime": "2018-12-20 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]分级诊疗难实现 医共体急需解决四大问题",
    "href": "http://stock.jrj.com.cn/2018/12/20000026838758.shtml",
    "datetime": "2018-12-20 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]集中采购试点工作进入实施阶段 消除药品购销灰色空间",
    "href": "http://stock.jrj.com.cn/2018/12/20000028068960.shtml",
    "datetime": "2018-12-20 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]药品临床评价明年加速,三大重点任务已定!",
    "href": "http://stock.jrj.com.cn/2018/12/20000027776480.shtml",
    "datetime": "2018-12-20 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]2018全国放射科专业住院医师规范化培训吉林站圆满落幕",
    "href": "http://stock.jrj.com.cn/2018/12/19000031534621.shtml",
    "datetime": "2018-12-19 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]2018全国放射科专业住院医师规范化培训吉林站圆满落幕",
    "href": "http://stock.jrj.com.cn/2018/12/19000031534809.shtml",
    "datetime": "2018-12-19 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]2018全国放射科专业住院医师规范化培训吉林站隆重开幕",
    "href": "http://stock.jrj.com.cn/2018/12/19000031534640.shtml",
    "datetime": "2018-12-19 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]集中采购试点工作进入实施阶段 消除药品购销灰色空间",
    "href": "http://stock.jrj.com.cn/2018/12/14000026742954.shtml",
    "datetime": "2018-12-14 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]最新带量采购:原研药不降价,就出局",
    "href": "http://stock.jrj.com.cn/2018/12/07000028068958.shtml",
    "datetime": "2018-12-07 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]药品临床评价明年加速,三大重点任务已定!",
    "href": "http://stock.jrj.com.cn/2018/12/07000025471432.shtml",
    "datetime": "2018-12-07 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]最新带量采购:原研药不降价,就出局",
    "href": "http://stock.jrj.com.cn/2018/11/29000025421170.shtml",
    "datetime": "2018-11-29 00:00:00",
    "code": "300016"
  },
  {
    "title": "北陆药业提“科创板”应声涨停 遭深交所问询",
    "href": "http://stock.jrj.com.cn/2018/11/22013925389752.shtml",
    "datetime": "2018-11-22 01:39:22",
    "code": "300016"
  },
  {
    "title": "北陆药业“花式”蹭热点：股价涨停了 问询函也来了",
    "href": "http://stock.jrj.com.cn/2018/11/21221325389176.shtml",
    "datetime": "2018-11-21 22:13:42",
    "code": "300016"
  },
  {
    "title": "北陆药业收关注函 被问是否蹭了科创板热点炒股价",
    "href": "http://stock.jrj.com.cn/2018/11/21142325387487.shtml",
    "datetime": "2018-11-21 14:23:58",
    "code": "300016"
  },
  {
    "title": "[天眼]北陆药业涉科创概念收关注函:是否迎合市场热点",
    "href": "http://stock.jrj.com.cn/2018/11/21122625387122.shtml",
    "datetime": "2018-11-21 12:26:00",
    "code": "300016"
  },
  {
    "title": "北陆药业涉科创概念 收到深交所关注函",
    "href": "http://stock.jrj.com.cn/2018/11/21112625386918.shtml",
    "datetime": "2018-11-21 11:26:56",
    "code": "300016"
  },
  {
    "title": "北陆药业涉科创概念 收到深交所关注函",
    "href": "http://stock.jrj.com.cn/2018/11/21111825386883.shtml",
    "datetime": "2018-11-21 11:18:00",
    "code": "300016"
  },
  {
    "title": "北陆药业董秘自曝创投概念拉涨停 盘后遭到深交所问询",
    "href": "http://stock.jrj.com.cn/2018/11/20204225381145.shtml",
    "datetime": "2018-11-20 20:42:16",
    "code": "300016"
  },
  {
    "title": "北陆药业:参股两公司力争实现IPO 密切关注科创板动态",
    "href": "http://stock.jrj.com.cn/2018/11/20120025378776.shtml",
    "datetime": "2018-11-20 12:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]国家药监局:药企、药商、药店,都做药品追溯",
    "href": "http://stock.jrj.com.cn/2018/11/16000025356885.shtml",
    "datetime": "2018-11-16 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]官方发文:未过一致性评价,注销批文!",
    "href": "http://stock.jrj.com.cn/2018/11/16000028068949.shtml",
    "datetime": "2018-11-16 00:00:00",
    "code": "300016"
  },
  {
    "title": "北陆药业：关于非公开发行限售股上市流通的提示性公告",
    "href": "http://stock.jrj.com.cn/2018/11/13210025340784.shtml",
    "datetime": "2018-11-13 21:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]官方发文:未过一致性评价,注销批文!",
    "href": "http://stock.jrj.com.cn/2018/11/08000025318189.shtml",
    "datetime": "2018-11-08 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]北陆药业晒2018“成绩单”:营收首破6亿 净利同比增长24%",
    "href": "http://stock.jrj.com.cn/2018/11/02000031534625.shtml",
    "datetime": "2018-11-02 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]北陆药业晒2018“成绩单”:营收首破6亿 净利同比增长24%",
    "href": "http://stock.jrj.com.cn/2018/11/02000031534799.shtml",
    "datetime": "2018-11-02 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]“九味·同行”系列活动顺利拉开帷幕",
    "href": "http://stock.jrj.com.cn/2018/11/02000031534800.shtml",
    "datetime": "2018-11-02 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]“九味·同行”系列活动顺利拉开帷幕",
    "href": "http://stock.jrj.com.cn/2018/11/02000031534626.shtml",
    "datetime": "2018-11-02 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]职场“新”人 | 焕新职场,礼仪先行",
    "href": "http://stock.jrj.com.cn/2018/11/01000031534801.shtml",
    "datetime": "2018-11-01 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]职场“新”人 | 焕新职场,礼仪先行",
    "href": "http://stock.jrj.com.cn/2018/11/01000031534628.shtml",
    "datetime": "2018-11-01 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]国家药监局公布:这些药可提前上市!",
    "href": "http://stock.jrj.com.cn/2018/11/01000025294027.shtml",
    "datetime": "2018-11-01 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]药品管理法修改:取消GMP/GSP认证,重罚违法药企",
    "href": "http://stock.jrj.com.cn/2018/11/01000028068950.shtml",
    "datetime": "2018-11-01 00:00:00",
    "code": "300016"
  },
  {
    "title": "北陆药业产品入选《国家基本药物目录》",
    "href": "http://stock.jrj.com.cn/2018/10/30174725281027.shtml",
    "datetime": "2018-10-30 17:47:23",
    "code": "300016"
  },
  {
    "title": "[北陆药业]爱心礼包 | 关爱员工,做健康北陆人!",
    "href": "http://stock.jrj.com.cn/2018/10/25000031534624.shtml",
    "datetime": "2018-10-25 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]爱心礼包 | 关爱员工,做健康北陆人!",
    "href": "http://stock.jrj.com.cn/2018/10/25000031534798.shtml",
    "datetime": "2018-10-25 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]药品管理法修改:取消GMP/GSP认证,重罚违法药企",
    "href": "http://stock.jrj.com.cn/2018/10/25000025259701.shtml",
    "datetime": "2018-10-25 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]北陆药业2018年前三季度业绩持续增长",
    "href": "http://stock.jrj.com.cn/2018/10/19000031534627.shtml",
    "datetime": "2018-10-19 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]北陆药业2018年前三季度业绩持续增长",
    "href": "http://stock.jrj.com.cn/2018/10/19000031534802.shtml",
    "datetime": "2018-10-19 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]近期药政重点:落实“两票制”,打击过票洗钱!",
    "href": "http://stock.jrj.com.cn/2018/10/18000025221033.shtml",
    "datetime": "2018-10-18 00:00:00",
    "code": "300016"
  },
  {
    "title": "北陆药业：2018年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/10/11211025189589.shtml",
    "datetime": "2018-10-11 21:10:03",
    "code": "300016"
  },
  {
    "title": "[北陆药业]造影计划 | 北陆药业“新人训”,抢先上墙!",
    "href": "http://stock.jrj.com.cn/2018/10/10000031534803.shtml",
    "datetime": "2018-10-10 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]造影计划 | 北陆药业“新人训”,抢先上墙!",
    "href": "http://stock.jrj.com.cn/2018/10/10000031534629.shtml",
    "datetime": "2018-10-10 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]北陆药业总经理王旭受邀参加BTV财经频道《京津冀大格局》栏目",
    "href": "http://stock.jrj.com.cn/2018/09/27000031534620.shtml",
    "datetime": "2018-09-27 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]北陆药业总经理王旭受邀参加BTV财经频道《京津冀大格局》栏目",
    "href": "http://stock.jrj.com.cn/2018/09/27000031534808.shtml",
    "datetime": "2018-09-27 00:00:00",
    "code": "300016"
  },
  {
    "title": "北陆药业股东拟减持不超480万股",
    "href": "http://stock.jrj.com.cn/2018/09/13174625088153.shtml",
    "datetime": "2018-09-13 17:46:38",
    "code": "300016"
  },
  {
    "title": "[北陆药业]中成药价格上涨 是“超前”还是“滞后”",
    "href": "http://stock.jrj.com.cn/2018/09/13000025087101.shtml",
    "datetime": "2018-09-13 00:00:00",
    "code": "300016"
  },
  {
    "title": "渝三峡A拟出售北陆药业不超480万股",
    "href": "http://stock.jrj.com.cn/2018/09/12192625083110.shtml",
    "datetime": "2018-09-12 19:26:56",
    "code": "300016"
  },
  {
    "title": "渝三峡A：拟减持480万股北陆药业股票",
    "href": "http://stock.jrj.com.cn/2018/09/12172625082593.shtml",
    "datetime": "2018-09-12 17:26:28",
    "code": "300016"
  },
  {
    "title": "渝三峡A：拟择机减持北陆药业不超过480万股",
    "href": "http://stock.jrj.com.cn/2018/09/12161025082231.shtml",
    "datetime": "2018-09-12 16:10:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]国家药监局:推动一致性评价 加快仿制药上市",
    "href": "http://stock.jrj.com.cn/2018/08/30000028068948.shtml",
    "datetime": "2018-08-30 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]北陆药业荣登BTV直播节目,响应“疏解非首都功能”做出突出贡献获赞。",
    "href": "http://stock.jrj.com.cn/2018/08/20000026838497.shtml",
    "datetime": "2018-08-20 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]国家药监局:推动一致性评价 加快仿制药上市",
    "href": "http://stock.jrj.com.cn/2018/08/09000024930080.shtml",
    "datetime": "2018-08-09 00:00:00",
    "code": "300016"
  },
  {
    "title": "上半年净利同比增18%拟10转5 北陆药业涨停",
    "href": "http://stock.jrj.com.cn/2018/08/06100024909693.shtml",
    "datetime": "2018-08-06 10:00:35",
    "code": "300016"
  },
  {
    "title": "北陆药业：业绩符合预期 静待价值重估",
    "href": "http://stock.jrj.com.cn/2018/08/06092024909424.shtml",
    "datetime": "2018-08-06 09:20:00",
    "code": "300016"
  },
  {
    "title": "北陆药业：上半年净利8469万元同比增18% 拟10转5",
    "href": "http://stock.jrj.com.cn/hotstock/2018/08/06080024908972.shtml",
    "datetime": "2018-08-06 08:00:00",
    "code": "300016"
  },
  {
    "title": "北陆药业：2018年半年度报告主要财务指标及分配预案",
    "href": "http://stock.jrj.com.cn/2018/08/03212024903697.shtml",
    "datetime": "2018-08-03 21:20:00",
    "code": "300016"
  },
  {
    "title": "北陆药业上半年净利同比增18% 拟10转5",
    "href": "http://stock.jrj.com.cn/2018/08/03174624903040.shtml",
    "datetime": "2018-08-03 17:46:43",
    "code": "300016"
  },
  {
    "title": "北陆药业：上半年净利增18% 拟10转5",
    "href": "http://stock.jrj.com.cn/2018/08/03155524902513.shtml",
    "datetime": "2018-08-03 15:55:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]国家基药政策,或有大调整",
    "href": "http://stock.jrj.com.cn/2018/08/03000024902460.shtml",
    "datetime": "2018-08-03 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]国家医保局开会了 传递重要信号",
    "href": "http://stock.jrj.com.cn/2018/07/12000024827606.shtml",
    "datetime": "2018-07-12 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]分级诊疗难实现 医共体急需解决四大问题",
    "href": "http://stock.jrj.com.cn/2018/07/12000027918745.shtml",
    "datetime": "2018-07-12 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]创新药企大利好!新规发布强化药品审评审批保密制度",
    "href": "http://stock.jrj.com.cn/2018/07/12000027776477.shtml",
    "datetime": "2018-07-12 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]北陆药业荣登BTV直播节目,响应“疏解非首都功能”做出突出贡献获赞。",
    "href": "http://stock.jrj.com.cn/2018/07/03000027919976.shtml",
    "datetime": "2018-07-03 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]一文了解政府工作报告2018医药重点任务",
    "href": "http://stock.jrj.com.cn/2018/06/29000027526561.shtml",
    "datetime": "2018-06-29 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]进口药加速审评审批带来挑战,本土药企研发别忽视这五点!",
    "href": "http://stock.jrj.com.cn/2018/06/29000027918737.shtml",
    "datetime": "2018-06-29 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]化学仿制药注射剂注册申请 五种情况需现场检查",
    "href": "http://stock.jrj.com.cn/2018/06/29000027776476.shtml",
    "datetime": "2018-06-29 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]创新药企大利好!新规发布强化药品审评审批保密制度",
    "href": "http://stock.jrj.com.cn/2018/06/29000028073984.shtml",
    "datetime": "2018-06-29 00:00:00",
    "code": "300016"
  },
  {
    "title": "北陆药业拟1.37亿元认购海昌药业1140万股",
    "href": "http://stock.jrj.com.cn/2018/06/19195625274083.shtml",
    "datetime": "2018-06-19 19:56:00",
    "code": "300016"
  },
  {
    "title": "北陆药业拟1.37亿元认购海昌药业1140万股",
    "href": "http://stock.jrj.com.cn/2018/06/19195627631273.shtml",
    "datetime": "2018-06-19 19:56:00",
    "code": "300016"
  },
  {
    "title": "北陆药业拟1.37亿元认购海昌药业1140万股",
    "href": "http://stock.jrj.com.cn/2018/06/19195628072224.shtml",
    "datetime": "2018-06-19 19:56:00",
    "code": "300016"
  },
  {
    "title": "北陆药业拟1.37亿元认购海昌药业1140万股",
    "href": "http://stock.jrj.com.cn/2018/06/19195628259878.shtml",
    "datetime": "2018-06-19 19:56:00",
    "code": "300016"
  },
  {
    "title": "北陆药业拟1.37亿元认购海昌药业1140万股",
    "href": "http://stock.jrj.com.cn/2018/06/19195628462609.shtml",
    "datetime": "2018-06-19 19:56:00",
    "code": "300016"
  },
  {
    "title": "北陆药业拟1.37亿元认购海昌药业1140万股",
    "href": "http://stock.jrj.com.cn/2018/06/19195627107775.shtml",
    "datetime": "2018-06-19 19:56:00",
    "code": "300016"
  },
  {
    "title": "北陆药业拟1.37亿元认购海昌药业1140万股",
    "href": "http://stock.jrj.com.cn/2018/06/19195627337734.shtml",
    "datetime": "2018-06-19 19:56:00",
    "code": "300016"
  },
  {
    "title": "北陆药业拟1.37亿元认购海昌药业1140万股",
    "href": "http://stock.jrj.com.cn/2018/06/19195627388488.shtml",
    "datetime": "2018-06-19 19:56:00",
    "code": "300016"
  },
  {
    "title": "北陆药业拟1.37亿元认购海昌药业1140万股",
    "href": "http://stock.jrj.com.cn/2018/06/19195627750496.shtml",
    "datetime": "2018-06-19 19:56:00",
    "code": "300016"
  },
  {
    "title": "北陆药业拟1.37亿元认购海昌药业1140万股",
    "href": "http://stock.jrj.com.cn/2018/06/19195627787085.shtml",
    "datetime": "2018-06-19 19:56:00",
    "code": "300016"
  },
  {
    "title": "北陆药业拟1.37亿元认购海昌药业1140万股",
    "href": "http://stock.jrj.com.cn/2018/06/19195627844340.shtml",
    "datetime": "2018-06-19 19:56:00",
    "code": "300016"
  },
  {
    "title": "北陆药业拟1.37亿元认购海昌药业1140万股",
    "href": "http://stock.jrj.com.cn/2018/06/19195628156613.shtml",
    "datetime": "2018-06-19 19:56:00",
    "code": "300016"
  },
  {
    "title": "北陆药业拟1.37亿元认购海昌药业1140万股",
    "href": "http://stock.jrj.com.cn/2018/06/19195628553728.shtml",
    "datetime": "2018-06-19 19:56:00",
    "code": "300016"
  },
  {
    "title": "北陆药业拟1.37亿元认购海昌药业1140万股",
    "href": "http://stock.jrj.com.cn/2018/06/19195627910775.shtml",
    "datetime": "2018-06-19 19:56:00",
    "code": "300016"
  },
  {
    "title": "北陆药业拟1.37亿元认购海昌药业1140万股",
    "href": "http://stock.jrj.com.cn/2018/06/19195628341413.shtml",
    "datetime": "2018-06-19 19:56:00",
    "code": "300016"
  },
  {
    "title": "北陆药业拟1.37亿元认购海昌药业1140万股",
    "href": "http://stock.jrj.com.cn/2018/06/19195628515296.shtml",
    "datetime": "2018-06-19 19:56:00",
    "code": "300016"
  },
  {
    "title": "北陆药业拟1.37亿元认购海昌药业1140万股",
    "href": "http://stock.jrj.com.cn/2018/06/19195628667908.shtml",
    "datetime": "2018-06-19 19:56:00",
    "code": "300016"
  },
  {
    "title": "北陆药业认购海昌药业33.5%的股权",
    "href": "http://stock.jrj.com.cn/2018/06/19182824698154.shtml",
    "datetime": "2018-06-19 18:28:49",
    "code": "300016"
  },
  {
    "title": "北陆药业拟1.37亿元认购海昌药业1140万股",
    "href": "http://stock.jrj.com.cn/2018/06/19180224698058.shtml",
    "datetime": "2018-06-19 18:02:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]医保目录调整品种放量明显 医药行业反转向好!",
    "href": "http://stock.jrj.com.cn/2018/06/15000027918742.shtml",
    "datetime": "2018-06-15 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]化学仿制药注射剂注册申请 五种情况需现场检查",
    "href": "http://stock.jrj.com.cn/2018/06/15000028073981.shtml",
    "datetime": "2018-06-15 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]国务院:医院改革,这38地最好!",
    "href": "http://stock.jrj.com.cn/2018/06/08000027776478.shtml",
    "datetime": "2018-06-08 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]注射剂迎现场核查,进口药、变更工艺是下一站",
    "href": "http://stock.jrj.com.cn/2018/06/08000027918739.shtml",
    "datetime": "2018-06-08 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]国务院:医院改革,这38地最好!",
    "href": "http://stock.jrj.com.cn/2018/06/01000028073982.shtml",
    "datetime": "2018-06-01 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]2018,卫计委的10项重点任务公布",
    "href": "http://stock.jrj.com.cn/2018/06/01000027918735.shtml",
    "datetime": "2018-06-01 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]2018,卫计委的10项重点任务公布",
    "href": "http://stock.jrj.com.cn/2018/05/24000026838757.shtml",
    "datetime": "2018-05-24 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]创新药企大利好!新规发布强化药品审评审批保密制度",
    "href": "http://stock.jrj.com.cn/2018/05/24000024585685.shtml",
    "datetime": "2018-05-24 00:00:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]化学仿制药注射剂注册申请 五种情况需现场检查",
    "href": "http://stock.jrj.com.cn/2018/05/17000024552877.shtml",
    "datetime": "2018-05-17 00:00:00",
    "code": "300016"
  },
  {
    "title": "医药板块午后走强 北陆药业强势涨停",
    "href": "http://stock.jrj.com.cn/2018/05/15141324541831.shtml",
    "datetime": "2018-05-15 14:13:12",
    "code": "300016"
  },
  {
    "title": "医药股午后走强 北陆药业涨停",
    "href": "http://stock.jrj.com.cn/2018/05/15134524541716.shtml",
    "datetime": "2018-05-15 13:45:00",
    "code": "300016"
  },
  {
    "title": "北陆药业：关于终止筹划重大资产重组暨股票复牌的公告",
    "href": "http://stock.jrj.com.cn/2018/05/08191024511341.shtml",
    "datetime": "2018-05-08 19:10:00",
    "code": "300016"
  },
  {
    "title": "北陆药业：终止筹划重大资产重组 明日复牌",
    "href": "http://stock.jrj.com.cn/2018/05/08172024510688.shtml",
    "datetime": "2018-05-08 17:20:00",
    "code": "300016"
  },
  {
    "title": "北陆药业终止筹划重大资产重组事项 9日起复牌",
    "href": "http://stock.jrj.com.cn/2018/05/08170824510670.shtml",
    "datetime": "2018-05-08 17:08:00",
    "code": "300016"
  },
  {
    "title": "[北陆药业]国务院:医院改革,这38地最好!",
    "href": "http://stock.jrj.com.cn/2018/05/04000024493245.shtml",
    "datetime": "2018-05-04 00:00:00",
    "code": "300016"
  }
]